Transplantation of Reduced-Size Fatty Livers
缩小脂肪肝移植
基本信息
- 批准号:7430496
- 负责人:
- 金额:$ 25.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosine4 hydroxynonenalAccountingAcetylcysteineAdenovirusesAffectAntibodiesAntioxidantsApoptosisArtsBilirubinBromodeoxyuridineCaloriesCell CycleCell ProliferationCellular biologyClinicComplexConditionCorn OilCryopreservationCyclin D1CyclosporineCysteineCytosolDataDevelopmentDietEGF geneElectron Spin Resonance SpectroscopyEnergy SupplyEnzymesFailureFatty LiverFatty acid glycerol estersFigs - dietaryFluorescent ProbesFree RadicalsFreezingFrightFunctional disorderGene DeliveryGenesGoalsGraft SurvivalGrowth FactorHarvestHepaticHepatic MassHistologyHydrogen PeroxideHypoxiaImageImmunohistochemistryImmunosuppressive AgentsImplantIncidenceInfiltrationInjuryInterleukin-6Lactated Ringer&aposs SolutionLiverLiver RegenerationLiving Donor Liver TransplantationManganese Superoxide DismutaseMeasurementMediatingMembrane PotentialsMicrocirculationMicroscopyMitochondriaMitochondrial SwellingMitoticModelingMolecular Biology TechniquesNG-Nitroarginine Methyl EsterNatural regenerationNecrosisNitratesNitric OxideNitric Oxide SynthaseNitritesNitrogenObese MiceOutcomeOxidation-ReductionOxygenPan GenusPathway interactionsPermeabilityPeroxonitritePimonidazolePlayPloidiesPrincipal InvestigatorProductionProliferating Cell Nuclear AntigenRateRattusReactive Oxygen SpeciesReagentResearch PersonnelRespiratory ChainRoleSTAT3 geneSerumSeveritiesSignal Transduction PathwaySolutionsSourceSpin TrappingStaining methodStainsStressSuperoxide DismutaseSuperoxidesTechniquesTestingTimeTransplantationTriglyceridesUCP2 proteinUniversity of Wisconsin-lactobionate solutionWeekWestern BlottingWorkadductalpha-(4-pyridyl-1-oxide)-N-tert-butylnitroneanalogbasecholine deficient dietclinical applicationcytochrome ccytokinedayfeedingfluorexonfluorophoregraft failuregraft functionhuman NOS2A proteinhuman SOD2 proteinimmunocytochemistryimplantationimprovedin vivoinhibitor/antagonistinsightintravital video microscopyliver functionliver transplantationmitochondrial dysfunctionmitochondrial membranenitratenon-alcoholicoil red Opolyphenolpreventprogramsresearch studysizetetramethylrhodamine methyl estertranscription factor
项目摘要
DESCRIPTION (provided by applicant): Fatty livers are rarely used for partial liver transplantation due to the fear of primary non-function. These studies are to elucidate mechanisms and to develop strategies to prevent failure of fatty partial grafts. We will use reduced-size rat liver transplantation to test the unique hypotheses that steatosis and partial liver transplantation synergistically increase reactive oxygen and nitrogen species (ROS and RNS), inhibit mitochondrial function and suppress liver regeneration. In Aim 1, we will investigate if steatosis increases graft failure after partial liver transplantation. Fatty livers will be induced by high fat diet and choline-deficient diet, respectively, and reduced to 30% to 50% of original size. We will assess survival, liver function, and histology after transplantation as a function of steatosis, graft volume and cold storage time. In Aim 2, we will test the hypothesis that ROS and RNS are increased in high-fat diet-induced fatty partial grafts, leading to injury. ROS will be determined by the spin-trapping technique and immunohistochemistry for 4-hydroxynonenal and RNS will be assessed as nitrotyrosine and nitrite/nitrate levels. We expect that ROS and RNS production will be higher in fatty than lean partial grafts. We will also identify cellular sources of ROS and RNS using fluorescent intravital multiphoton microscopy. The effects of antioxidants (Ad-superoxide dismutase, N-acetylcysteine and polyphenols) and antinitrative therapies (nitric oxide synthase inhibitors) on survival and injury of fatty partial grafts will be evaluated. In Aim 3, effects of steatosis and graft volume on energy supply will be evaluated. Uncoupling protein 2, mitochondrial permeability transition and respiratory chain activity will be determined to elucidate the mechanisms of defective energy production, and effects of mitochondrial permeability transition inhibitors and antioxidant and antinitrative therapies on mitochondrial function will be evaluated. In Aim 4, the effects of steatosis and graft volume on liver regeneration will be assessed. Cell proliferation and factors regulating regeneration (cytokines, transcription factors, growth factors, and cell cycle related genes) will be evaluated. In addition, we will investigate if protection of mitochondria function and antioxidative and antinitrative therapies improve liver regeneration. Taken together, we expect that this work will provide fundamental new insights into the mechanisms underlying reduced-size fatty graft failure and develop mechanism-based strategies to increase the use and improve the outcome of fatty livers for partial liver transplantation in the clinic.
描述(申请人提供):由于担心原发性无功能,脂肪肝很少用于部分肝移植。这些研究旨在阐明机制并制定防止部分脂肪移植失败的策略。我们将使用缩小尺寸的大鼠肝移植来测试脂肪变性和部分肝移植协同增加活性氧和氮(ROS和RNS)、抑制线粒体功能并抑制肝再生的独特假设。在目标 1 中,我们将研究脂肪变性是否会增加部分肝移植后的移植失败。高脂肪饮食和缺乏胆碱饮食会分别诱发脂肪肝,并缩小至原来大小的30%至50%。我们将评估移植后的存活率、肝功能和组织学,作为脂肪变性、移植物体积和冷藏时间的函数。在目标 2 中,我们将检验以下假设:高脂肪饮食诱导的脂肪部分移植物中 ROS 和 RNS 增加,从而导致损伤。 ROS 将通过自旋捕获技术和 4-羟基壬烯醛的免疫组织化学测定,RNS 将评估硝基酪氨酸和亚硝酸盐/硝酸盐水平。我们预计脂肪部分移植物中的 ROS 和 RNS 产量将高于瘦肉部分移植物。我们还将使用荧光活体多光子显微镜来识别 ROS 和 RNS 的细胞来源。将评估抗氧化剂(Ad-超氧化物歧化酶、N-乙酰半胱氨酸和多酚)和抗硝疗法(一氧化氮合酶抑制剂)对脂肪部分移植物的存活和损伤的影响。在目标 3 中,将评估脂肪变性和移植物体积对能量供应的影响。将确定解偶联蛋白 2、线粒体通透性转变和呼吸链活性,以阐明能量产生缺陷的机制,并评估线粒体通透性转变抑制剂以及抗氧化剂和抗硝化疗法对线粒体功能的影响。在目标 4 中,将评估脂肪变性和移植物体积对肝再生的影响。将评估细胞增殖和再生调节因子(细胞因子、转录因子、生长因子和细胞周期相关基因)。此外,我们将研究保护线粒体功能以及抗氧化和抗硝疗法是否可以改善肝再生。总而言之,我们期望这项工作将为减少脂肪移植失败的机制提供根本性的新见解,并制定基于机制的策略,以增加脂肪肝在临床上部分肝移植的使用并改善其结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHI ZHONG其他文献
ZHI ZHONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHI ZHONG', 18)}}的其他基金
Mechanisms of In Vivo Ethanol-Induced Mitochondrial Depolarization
体内乙醇诱导线粒体去极化的机制
- 批准号:
7522902 - 财政年份:2009
- 资助金额:
$ 25.63万 - 项目类别:
Improvement of Liver Transplantation by a Sphingosine Kinase Inhibitor
鞘氨醇激酶抑制剂改善肝移植
- 批准号:
7745865 - 财政年份:2009
- 资助金额:
$ 25.63万 - 项目类别:
Mechanisms of In Vivo Ethanol-Induced Mitochondrial Depolarization
体内乙醇诱导线粒体去极化的机制
- 批准号:
7896824 - 财政年份:2009
- 资助金额:
$ 25.63万 - 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
- 批准号:
6611398 - 财政年份:2002
- 资助金额:
$ 25.63万 - 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
- 批准号:
6752765 - 财政年份:2002
- 资助金额:
$ 25.63万 - 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
- 批准号:
6521489 - 财政年份:2002
- 资助金额:
$ 25.63万 - 项目类别:
相似国自然基金
预先修饰半胱氨酸通过抑制4-HNE-TRPA1敏化减少心肌缺血后损伤的保护机制
- 批准号:81900316
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
腌腊肉制品中氢过氧化十八碳二烯酸降解形成4-羟基壬烯醛的机制研究
- 批准号:31901716
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
肺动脉高压中4-HNE介导ET-1引起内皮细胞损伤的作用机制研究
- 批准号:81702059
- 批准年份:2017
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
Nrf-2/GSTs通路失活联合TKIs抑制CML干细胞肿瘤生成能力
- 批准号:81600134
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
4-羟基壬烯醛通过MAPK信号促进猪小肠上皮细胞凋亡、降低肠屏障功能的机理研究
- 批准号:31572410
- 批准年份:2015
- 资助金额:66.0 万元
- 项目类别:面上项目
相似海外基金
LRRK2 and oxidative stress in Parkinson’s disease
LRRK2 与帕金森病的氧化应激
- 批准号:
10799999 - 财政年份:2023
- 资助金额:
$ 25.63万 - 项目类别:
An Activity-Based Assay to Screen for PRMT1 Inhibitors
基于活动的 PRMT1 抑制剂筛选试验
- 批准号:
8324861 - 财政年份:2012
- 资助金额:
$ 25.63万 - 项目类别:
An Activity-Based Assay to Screen for PRMT1 Inhibitors
基于活动的 PRMT1 抑制剂筛选试验
- 批准号:
8460828 - 财政年份:2012
- 资助金额:
$ 25.63万 - 项目类别:
Localized Metal Modulation as a First Line Treatment of Burn Injuries
局部金属调制作为烧伤的一线治疗
- 批准号:
8252621 - 财政年份:2012
- 资助金额:
$ 25.63万 - 项目类别:
Regulatory Mechanisms of Oxidative Stress in Hypertensive Heart Disease
高血压性心脏病氧化应激的调节机制
- 批准号:
8109912 - 财政年份:2010
- 资助金额:
$ 25.63万 - 项目类别: